The first full body blue light (UV-free) device that addresses unmet needs in dermatology

The first full body blue light (UV-free) device that addresses unmet needs in dermatology
Changing the idea about psoriasis therapy.
For years, there have been different approaches to treating plaque psoriasis. Some of them can have lasting effects on your patients' bodies or cause limitations to their everyday lives. We at Phlecs have combined our extensive knowledge from many years of experience in healthcare and our expertise in creating innovative light solutions to make real change and redefine how patients as well as healthcare professionals approach psoriasis treatment.
With Blue LED Light Therapy we deliver innovation that matters to you and your patients.
Latest news
Recent clinical findings to aid individuals with eczema and enhance their emotional well-being
On World Atopic Eczema Day, Phlecs presents an innovative treatment approach aimed at addressing both the skin condition and the emotional well-being of patients.
Phlecs receives a new grant from EIT Health to start sales in Germany
Dutch MedTech start-up Phlecs as just been selected by EIT Health to participate in its Bridgehead Europe programme 2022.
Dutch MedTech start-up Phlecs receives the innovation award at the International Ageing Fit Conference in Lille (France)
Phlecs initiates the development project of a new generation of phototherapy blue light – UV free medical device: the Full Body Home Connected.
PHLECS receives a 50,000€ grant from Metropoolregio Eindhoven
Phlecs initiates the development project of a new generation of phototherapy blue light – UV free medical device: the Full Body Home Connected.
Blue Light Therapy clinical investigations in Poland
Interview of Professor Lesiak at the Polish national television – May 2021
English subtitles available
The power of Blue Light – phototherapy for recovering from COVID-19
AGATA RUCIŃSKA APRIL 12, 2021 Blue light, emitted by LED lamps, is one of the phototherapy methods that has been recently enjoying great popularity, ma ...
NEW STUDY ON BLUE LIGHT: The impact of non-toxic blue light (453 nm) on cellular antioxidative capacity, TGF-β1 signaling, and myofibrogenesis of human skin fibroblasts
Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the treatment of fibrotic skin diseases inc ...
PHLECS winner of the EIT Health’s Bridgehead Global program 2020
Dutch MedTech start-up PHLECS has just been selected by EIT Health to participate in its Bridgehead Global program. After receiving the CE marking for its Full ...